戻る Agenda
Making CRO-Sponsor Partnerships Work: Executive Roundtable
Session Chair(s)
Kenneth I. Kaitin, PHD
Professor and Senior Fellow
Tufts Center for the Study of Drug Development, United States
For the past several years, CROs and pharma companies have been forming strategic partnerships designed to improve quality and efficiency in the drug development process. But how strategic are they really? Where are the biggest gains being made? What are some of the pitfalls to avoid? Learn from senior thought leaders in the CRO and pharma industries who have broken new ground in the relationships between sponsors and CROs. These executives will share information on structure, governance, metrics and results.
Learning Objective : Discuss the biggest gains made by strategic partnerships; Describe some of the pitfalls to avoid with strategic partnerships.
Speaker(s)
Panelist
Jamie Macdonald
Parexel, United States
Chief Executive Officer
Panelist
Ciaran Murray
ICON plc, Ireland
Chief Executive Officer
Panelist
Peter A Carberry, MD, MBA
Astellas Pharma Global Development, Inc., United States
Senior Vice President, Global Development Operations
Panelist
Jonathan B Zung, PHD
WCG, United States
Executive Vice President, Site Division